Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D

, , , &
Journal of Law, Medicine and Ethics 50 (S2):47-54 (2022)
  Copy   BIBTEX

Abstract

The inclusion of antimicrobial resistance (AMR) and increased research and development (R&D) capabilities in the most recent outline of the World Health Organization’s (WHO’s) international pandemic instrument signals an opportunity to reshape pharmaceutical R&D system in favour of antimicrobial product development. This article explains why the current innovation ecosystem has disadvantaged the creation of antimicrobial products for human use. It also highlights how the COVID-19 pandemic experience can inform and stimulate international cooperation to implement innovative R&D incentives to bring new, life-saving antimicrobial products to the market.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2022.79

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,881

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

A Global Pandemic Treaty Must Address Antimicrobial Resistance.Lindsay A. Wilson, Susan Rogers Van Katwyk, Isaac Weldon & Steven J. Hoffman - 2021 - Journal of Law, Medicine and Ethics 49 (4):688-691.
Sustainable Development of the Innovation Ecosystem from the Perspective of T-O-V.Ruixue Yan, Jianlin Lv & Qingshi Meng - 2021 - Complexity 2021:1-14.
Innovation Contested: The Idea of Innovation Over the Centuries.Benoit Godin - 2015 - Routledge.
From Value Sensitive Design to values absorption – building an instrument to analyze organizational capabilities for value-sensitive innovation.Jilde Garst & Vincent Blok - 2022 - Journal of Responsible Innovation 1.
Conspiracism as a Litmus Test for Responsible Innovation.Vincent Blok & Eugen Octav Popa - 2022 - In Georgy Ishmaev Matthew J. Dennis (ed.), Values for a Post-Pandemic Future. Dordrecht, Nederland: pp. 111-128.
Utilitarian Lessons from the COVID-19 Pandemic for Non-Pandemic Diseases.Heather Browning & Walter Veit - 2021 - American Journal of Bioethics 21 (12):39-42.
Legal innovation in european contract law: Within and beyond the (draft) common frame of reference.Florian Möslein - unknown
Resource Scarcity and Humanitarian Social Innovation: Observations from Hunger Relief in the Context of the COVID-19 Pandemic.Iana Shaheen, Arash Azadegan & Donna F. Davis - 2022 - Journal of Business Ethics 182 (3):597-617.
Impact of the Extended Digital Eco-Dynamic on Innovation Performance: An Empirical Study on Small E-Businesses in Indonesia.Yuniarty Yuniarty, Idris Gautama So, Sri Bramantoro Abdinagoro & Mohammad Hamsal - 2022 - Frontiers in Psychology 13.
Innovation to Immune: Empirical Evidence From COVID-19 Focused Enterprise Surveys.Karamat Khan, Sheng Liu, Baowei Xiong, Leihao Zhang & Chuntao Li - 2022 - Frontiers in Psychology 13.
A trade‐off: Antimicrobial resistance and COVID‐19.Tess Johnson - 2021 - Bioethics 1 (1):1-9.
A trade-off: Antimicrobial resistance and COVID-19.Tess Johnson - 2021 - Bioethics 35 (9):947-955.
Knowledge and the regulation of innovation.Alfons Bora - 2010 - Poiesis and Praxis 7 (1-2):73-86.
A Motivational Mechanism Framework for Teachers' Online Informal Learning and Innovation During the COVID-19 Pandemic.Haiqin Yu, Jian Zhang & Ruomeng Zou - 2021 - Frontiers in Psychology 12.
An Empirical Study Evaluating the Symbiotic Efficiency of China’s Provinces and the Innovation Ecosystem in the High-Tech Industry.Jianzhao Yang - 2022 - Complexity 2022:1-14.

Analytics

Added to PP
2023-03-10

Downloads
10 (#1,193,888)

6 months
8 (#361,431)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references